Logopenic aphasia due to Lewy body disease dramatically improved with donepezil

Kazuo Kakinuma, Toru Baba, Michinori Ezura, Keiko Endo, Yumiko Saito, Wataru Narita, Osamu Iizuka, Yoshiyuki Nishio, Akio Kikuchi, Takafumi Hasegawa,

eNeurologicalSci · 2020 · 10 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

•Pathological basis of primary progressive aphasia is heterogeneous.•Logopenic primary progressive aphasia can precede dementia with Lewy bodies (DLB).•Cholinesterase inhibitor can improve logopenic aphasia with DLB.

References

8